Antiretroviral therapy interruptions: impact on HIV treatment and transmission

References

• UNAIDS [webpage on the Internet]AIDS by the Numbers 20162016 Available from: http://www.unaids.org/en/resources/documents/2016/Global-AIDSupdate-2016Accessed November 22, 2017
   Google Scholar
• GuyRWandHMcManusHAustralia HIV Observational Database (AHOD) and Treat Asia HIV Observation Database (TAHOD). Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for ‘test and treat’ prevention strategyAIDS Patient Care STDS2013271268169124320013
   PubMed Web of Science ®Google Scholar
• DubrocqGRakhmaninaNPhelpsBRChallenges and opportunities in the development of HIV medications in pediatric patientsPaediatr Drugs2017192919828074348
   PubMed Web of Science ®Google Scholar
• MacCarthySHoffmannMNunnASilvaLDouradoIBarriers to HIV testing, linkage to care, and treatment adherence: a cross-sectional study from a large urban center of BrazilRev Panam Salud Publica201640641842628718490
   PubMed Web of Science ®Google Scholar
• Strategies for Management of Antiretroviral Therapy (SMART) Study GroupEl-SadrWMLundgrenJCD4+ count-guided interruption of antiretroviral treatmentN Engl J Med2006355222283229617135583
   PubMed Web of Science ®Google Scholar
• JiamsakulAKerrSJNgOTTREAT Asia HIV Observational Database (TAHOD)Effects of unplanned treatment interruptions on HIV treatment failure – results from TAHODTrop Med Int Health201621566267426950901
   PubMed Web of Science ®Google Scholar
• BunupuradahTDuongTCompagnucciAPENTA 11 Extension Study GroupOutcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptionsAIDS201327457958923135172
   PubMed Web of Science ®Google Scholar
• CottonMFViolariAOtwombeKCHER Study TeamEarly limited antiretroviral therapy is superior to deferred therapy in HIV-infected South African infants: results from the CHER (Children with HIV Early antiRetroviral) randomized trialLancet201338299041555156324209829
   PubMed Web of Science ®Google Scholar
• WamalwaDBenki-NugentSLangatATreatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancyAIDS20163015230327177316
   PubMed Web of Science ®Google Scholar
• RakhmaninaNLamKSHernJYoungHAWaltersACastelADInterruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USAJ Int AIDS Soc20161912093627797320
   PubMed Web of Science ®Google Scholar
• ButlerKInshawJFordDBREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trialHealth Technol Assess201620491108
   Web of Science ®Google Scholar
• AnanworanichJMelvinDAmadorJTPENTA 11 Study GroupNeurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruptionAIDS20163071075108126730569
   PubMed Web of Science ®Google Scholar
• ImazAOlmoMPeñarandaMSTOPAR Study TeamEvolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapyAntivir Ther201217357722301439
   PubMed Web of Science ®Google Scholar
• ImazAOlmoMPeñarandaMSTOPAR Study TeamShort-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune functionAntivir Ther201318112522805174
   PubMed Web of Science ®Google Scholar
• BaroncelliSGalluzzoCMAndreottiMHIV-1 coreceptor switch during 2 years of structured treatment interruptionsEur J Clin Microbiol Infect Dis20133212156524213914
   PubMed Web of Science ®Google Scholar
• McLindenRParisRPolonisVAssociation of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)AIDS20122611145222767347
   PubMed Web of Science ®Google Scholar
• AssoumouLWeissLPikettyCANRS 116 SALTO Study GroupA low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral controlAIDS201529152003200726355572
   PubMed Web of Science ®Google Scholar
• ClarridgeKEBlazkovaJEinkaufKEffect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individualsPLoS Pathog2018141e100679229324842
   PubMed Web of Science ®Google Scholar
• BarKJSnellerMCHarrisonLJEffect of HIV antibody VRC01 on viral rebound after treatment interruptionN Engl J Med2016375212037205027959728
   PubMed Web of Science ®Google Scholar
• PenazzatoMPrendergastAJMuheLMTindyebwaDAbramsEOptimisation of antiretroviral therapy in HIV-infected children under 3 years of ageCochrane Database Syst Rev20145CD004772
   Google Scholar
• ColebundersRMusiimeVDoes the CHER trial open up new therapeutic perspectives?Lancet201338299041539154024209812
   PubMed Web of Science ®Google Scholar
• KleinNSefeDMosconiIPaediatric European Network for Treatment of AIDS 11 Trial TeamThe immunological and virological consequences of planned treatment interruptions in children with HIV infectionPLoS One2013810e7658224194841
   PubMed Web of Science ®Google Scholar
• SiberryGKPatelKVan DykeRBPediatric HIV/AIDS Cohort Study (PHACS)CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruptionJ Acquir Immune Defic Syndr201157322322921423022
   PubMed Web of Science ®Google Scholar
• MaggioloFAiroldiMCallegaroACD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAARTAIDS200923779980719114869
   PubMed Web of Science ®Google Scholar
• Robustillo-CortésMJiménez-GalánRGómez-FernándezEDI-076 interruption and discontinuation of highly active antiretroviral therapy in PSITAR HIV cohortEur J Hosp Pharm201522suppl 1A104
   Google Scholar
• JoyceVRBarnettPGChowAEffect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trialMed Decis Making20123217021383086
   PubMed Web of Science ®Google Scholar
• CohenMSChenYQMcCauleyMHPTN 052 Study TeamAntiretroviral therapy for the prevention of HIV-1 transmissionN Engl J Med2016375983083927424812
   PubMed Web of Science ®Google Scholar
• DonnellDBaetenJMKiarieJPartners in Prevention HSV/HIV Transmission Study TeamHeterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysisLancet201037597312092209820537376
   PubMed Web of Science ®Google Scholar
• BaetenJMDonnellDNdasePPartners PrEP Study TeamAntiretroviral prophylaxis for HIV prevention in heterosexual men and womenN Engl J Med2012367539941022784037
   PubMed Web of Science ®Google Scholar
• ReynoldsSJMakumbiFNakigoziGHIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapyAIDS201125447347721160416
   PubMed Web of Science ®Google Scholar
• JeanKGabillardDMohREffect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Côte d’IvoireJ Infect Dis2014209343144023990567
   PubMed Web of Science ®Google Scholar
• AnanworanichJFauciASHIV cure research: a formidable challengeJ Virus Erad2015111327482389
   PubMedGoogle Scholar